January 10, 2025 09:41 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
8 labourers still trapped in Assam's flooded mine even after 3 days of rescue ops | SC refuses to hear petitions seeking review of its same-sex marriage judgement, says there is 'no error' | 'They should wind up the alliance': Omar Abdullah on AAP-Congress fight over Delhi elections | Pune woman killed by her colleague in full public view for not paying back his money, no one intervenes | Los Angeles wildfire leaves 5 dead, forces 1 lakh including celebs to flee, Hollywood hills ablazed | PM Modi condoles death of six people in Tirupati stampede incident | Days after condemning Pak airstrikes, India in a first engages with Afghanistan's Taliban regime | 6 dead in stampede near Tirupati temple during token distribution to offer prayers | Prominent journalist-film producer Pritish Nandy dies of cardiac arrest at 73 | Thousands, including Hollywood stars, flee Los Angeles upscale neighbourhood as wildfire engulfs homes
Cipla's generic version of Remdesivir to be cheapest among rivals: Report

Cipla's generic version of Remdesivir to be cheapest among rivals: Report

Jul 09, 2020, at 05:39 am

Bengaluru/IBNS: Indian drug company Cipla has priced its generic version of Remdesivir, named Cipremi, at Rs 4,000 or USD 53.34 per 100 mg vial, making it the lowest priced versions of the COVID-19 treatment, a Reuters report said.

Cipla Limited launches generic remdesivir ‘Cipremi’ to fight COVID-19

Cipla Limited launches generic remdesivir ‘Cipremi’ to fight COVID-19

Jun 22, 2020, at 05:26 pm

New Delhi: Homegrown pharma major Cipla Limited on Monday announced the launch of remdesivir under its brand name Cipremi.